_PRIVATE_LIMITED.webp)
Acme Therapeutics (I) Profile
Key Indicators
- Authorised Capital ₹ 1.80 M
- Paid Up Capital ₹ 1.62 M
- Company Age 23 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 5.08 Cr
- Satisfied Charges ₹ 7.70 M
- Revenue Growth 4.01%
- Profit Growth -0.14%
- Ebitda -1.64%
- Net Worth 13.16%
- Total Assets 2.26%
About Acme Therapeutics (I)
Acme Therapeutics (I) Private Limited (ATIPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 14 March 2001 and has a history of 23 years and 11 months. Its registered office is in Panchkula, Haryana, India.
The Corporate was formerly known as Acme Pharmaceuticals Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.80 M and a paid-up capital of Rs 1.62 M.
The company currently has active open charges totaling ₹5.08 Cr. The company has closed loans amounting to ₹7.70 M, as per Ministry of Corporate Affairs (MCA) records.
Gopal Krishna, Banshidhar Kanhaiyalal, and Sanjay Kumar serve as directors at the Company.
Company Details
- Location
Panchkula, Haryana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U24232HR2001PTC093261
- Company No.
014592
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
14 Mar 2001
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Pharma
Who are the key members and board of directors at Acme Therapeutics (I)?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Gopal Krishna  | Director | 01-May-2002 | Current |
| Banshidhar Kanhaiyalal | Director | 14-Mar-2001 | Current |
| Sanjay Kumar | Director | 21-Oct-2019 | Current |
Financial Performance of Acme Therapeutics (I).
Acme Therapeutics (I) Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 4.01% increase. The company also saw a slight decrease in profitability, with a 0.14% decrease in profit. The company's net worth Soared by an impressive increase of 13.16%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Acme Therapeutics (I)?
In 2023, Acme Therapeutics (I) had a promoter holding of 95.69% and a public holding of 4.31%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Evets Drugs Private LimitedBanshidhar Kanhaiyalal is a mutual person
- Sriram Healthcare Private Limited
Banshidhar Kanhaiyalal is a mutual person
- Prosperity Drugs Private Limited
Banshidhar Kanhaiyalal is a mutual person
- Evets Packaging Private Limited
Banshidhar Kanhaiyalal is a mutual person
- Evets Glass & Polymer Private Limited
Banshidhar Kanhaiyalal is a mutual person
Charges (Loans)
Open Charges
₹50.83 M
Satisfied Charges
₹7.70 M
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 2.75 Cr
- Others : 2.33 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 27 Jan 2025 | Hdfc Bank Limited | ₹2.75 Cr | Open |
| 13 Feb 2024 | Others | ₹1.50 Cr | Open |
| 20 Mar 2020 | Others | ₹8.33 M | Open |
| 10 Dec 2015 | Kotak Mahindra Bank Limited | ₹4.20 M | Satisfied |
| 03 Jun 2004 | Punjab National Bank | ₹3.50 M | Satisfied |
How Many Employees Work at Acme Therapeutics (I)?
Acme Therapeutics (I) has a workforce of 302 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Acme Therapeutics (I), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Acme Therapeutics (I)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Latest Updates, News, and FAQs on Acme Therapeutics (I)
Recent activity within the organization
- Charges
A charge with Hdfc Bank Limited amounted to Rs. 27.50 M with Charge ID 101049295 was registered on 27 Jan 2025.
- Annual General Meeting
Acme Therapeutics (I) Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
- Balance Sheet
Acme Therapeutics (I) Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi.
- Charges
A charge with Others amounted to Rs. 15.00 M with Charge ID 100875794 was registered on 13 Feb 2024.
- Charges
A charge with Others amounted to Rs. 8.33 M with Charge ID 100341247 was registered on 20 Mar 2020.
- Charges
A charge registered on 10 Dec 2015 via Charge ID 10615973 with Kotak Mahindra Bank Limited was fully satisfied on 16 Mar 2020.
Frequently asked questions
What is the Incorporation or founding date of Acme Therapeutics (I) Private Limited?
Acme Therapeutics (I) Private Limited was incorporated on 14 Mar 2001.
What is authorized share capital and paid-up capital of Acme Therapeutics (I) Private Limited?
The authorized share capital of Acme Therapeutics (I) Private Limited is ₹ 1.80 M and paid-up capital is ₹ 1.62 M.
Who are the current board members & directors of Acme Therapeutics (I) Private Limited?
Currently 3 directors are associated with Acme Therapeutics (I) Private Limited.
- Gopal Krishna
- Banshidhar Kanhaiyalal
- Sanjay Kumar
What is the registered address of Acme Therapeutics (I) Private Limited?
As per Ministry of Corporate Affairs (Mca), the registered address of Acme Therapeutics (I) Private Limited is Flat No 1601 Tower 7A Suncity Parikrama, Sector 20 India, Panchkula, Haryana, 134109.
What is the corporate identification number (CIN) and company number of Acme Therapeutics (I) Private Limited?
The corporate identification number (CIN) of Acme Therapeutics (I) Private Limited is U24232HR2001PTC093261 and the company number is 014592 as per Ministry of Corporate Affairs (MCA).
What is the official website of Acme Therapeutics (I) Private Limited?
The Official website of Acme Therapeutics (I) Private Limited is https://www.atipl.in
What has been the recent revenue trend for Acme Therapeutics (I) Private Limited?
According to the financial reports for the fiscal year 2023, the revenue trend for Acme Therapeutics (I) Private Limited has risen by 4.01%.
How many employees does Acme Therapeutics (I) Private Limited currently have?
As Per 2023 financial reports, 302 employees are currently employed by Acme Therapeutics (I) Private Limited.
What change has been observed in the net worth of Acme Therapeutics (I) Private Limited, and by what percentage?
The financial reports for the fiscal year 2023 indicates that The net worth of Acme Therapeutics (I) Private Limited has experienced an upsurge of 13.16%.
What are the total open charges for Acme Therapeutics (I) Private Limited?
As per the financial statements for fiscal Year 2023, The total open charges for Acme Therapeutics (I) Private Limited amount to ₹ 5.08 Cr.
When was the last Balance Sheet of Acme Therapeutics (I) Private Limited filed with the ROC?
The most recent Balance Sheet for Acme Therapeutics (I) Private Limited was filed with the ROC on 31 Mar 2024.
People also Viewed
BA
Binod AgarwalDirectorVA
Vijay AgrawalDirectorMK
Murlidhar KanhaiyalalDirectorRJ
Rajesh JainDirector